KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $1.8 million.

  • Staar Surgical's Free Cash Flow rose 17387.16% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.5 million, marking a year-over-year decrease of 25037.84%. This contributed to the annual value of -$7.7 million for FY2024, which is 11338.34% down from last year.
  • Latest data reveals that Staar Surgical reported Free Cash Flow of $1.8 million as of Q3 2025, which was up 17387.16% from -$29.0 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Free Cash Flow ranged from a high of $28.9 million in Q4 2023 and a low of -$29.0 million during Q2 2025
  • For the 5-year period, Staar Surgical's Free Cash Flow averaged around $295800.0, with its median value being $364500.0 (2022).
  • In the last 5 years, Staar Surgical's Free Cash Flow tumbled by 25517.69% in 2022 and then surged by 283753.55% in 2023.
  • Quarter analysis of 5 years shows Staar Surgical's Free Cash Flow stood at $3.8 million in 2021, then plummeted by 127.7% to -$1.1 million in 2022, then surged by 2837.54% to $28.9 million in 2023, then crashed by 117.6% to -$5.1 million in 2024, then surged by 135.1% to $1.8 million in 2025.
  • Its Free Cash Flow stands at $1.8 million for Q3 2025, versus -$29.0 million for Q2 2025 and -$7.2 million for Q1 2025.